Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 1/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.38 |
| ▸ | CNR1 | P21554 | 2/20 | 0.38 |
| ▸ | CNR2 | P34972 | 2/20 | 0.38 |
| ▸ | MMP1 | P03956 | 2/20 | 0.37 |
| ▸ | MMP3 | P08254 | 2/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 8/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2864322 | 0.99 | MME (0.40) | MMES1PR1S1PR3TRPV1CNR1 | |
| SCHEMBL2451834 | 0.95 | MME (0.41) | MMES1PR1S1PR3TRPV1CNR1 | |
| SCHEMBL2860555 | 0.90 | S1PR1 (0.39) | MMES1PR1S1PR3TRPV1CNR1 | |
| SCHEMBL2450293 | 0.89 | MME (0.48) | MMEMMP1MMP3 | |
| SCHEMBL2863809 | 0.88 | MME (0.38) | MMES1PR1S1PR3TRPV1CNR1 | |
| SCHEMBL2448444 | 0.84 | MME (0.39) | MMES1PR1S1PR3TRPV1CNR1 | |
| SCHEMBL2457380 | 0.83 | CXCR2 (0.37) | MMEMMP1MMP3 | |
| SCHEMBL27585361 | 0.82 | TRPV1 (0.58) | TRPV1CNR1CNR2 | |
| SCHEMBL2453323 | 0.78 | MMP1 (0.38) | MMEMMP1MMP3EPHX1 | |
| SCHEMBL2449975 | 0.78 | MME (0.45) | MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7696380-B2 | Such as 1,2,3-propanetricarboxylic acid tris(trans-2-methylcycloheylamide; nucleation | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2010-04-13 | — | — | US | disclosed |
| US-20070066687-A1 | Amide-based compound, polyolefin resin composition and molded product | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2007-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066687-A1 | Amide-based compound, polyolefin resin composition and molded product | NAA50, ARG1, RFT1 | MME 3683/4885S1PR1 2109/4885S1PR3 2019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.